EBV gp350 is an envelope protein detectable in NPC specimens intracellularly and on the cell membrane of malignant cells, and is a potential viral antigen for T cell-directed immunotherapies. This evidence concerns the gene ERVW-1 and nasopharyngeal carcinoma.